Strategies to Improve Asthma and Treatment of Asthma in Canadians

NCT ID: NCT01525381

Last Updated: 2016-03-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

701 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-11-30

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Our study will enroll 644 randomly-selected Canadians who have been diagnosed with asthma by a physician within the previous five years. It will be determined what diagnostic tests were initially performed to make this diagnosis. Participants will undergo lung function testing over 6-8 weeks to determine their respiratory status and to confirm they have asthma. Participants may be followed up to one year depending on their test results.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patient must have a recent diagnosis of asthma by a physician. Diagnosis of asthma must have occurred within 5 years prior to entry into the study.
2. Patient must be at least 18 years old.

Exclusion Criteria

1. Patients in whom methacholine challenge is contraindicated

* Patients using chronic oral prednisone.
* Patients with heart attack or stroke within three previous months, and those with known aortic or cerebral aneurysms.
* Pregnant patients (unknown effect of methacholine on the fetus) and breastfeeding patients (unknown whether methacholine is excreted in breast milk).
2. Patients unable to provide informed consent.
3. Patients not able to perform spirometry and/or methacholine challenge testing.
4. Patients who have a greater than 10 pack-year smoking history (this will exclude patients with possible COPD).
5. Patients who currently have active pulmonary Tuberculosis
6. Patients who have had eye surgery in the past 3 months or who have a detached retina
7. Patients involved in another interventional asthma study
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ottawa Hospital Research Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shawn Aaron, MD

Role: PRINCIPAL_INVESTIGATOR

Ottawa Hosptial Research Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ottawa Hospital

Ottawa, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-221

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study in Patients With Asthma
NCT00215358 COMPLETED PHASE2
Molecular Mechanism of Asthma
NCT00180726 WITHDRAWN NA
Study of the Mechanisms of Asthma
NCT00595153 COMPLETED PHASE1
Statin Treatment in Patients With Asthma
NCT00292201 TERMINATED PHASE2